Substance P stimulates the opossum sphincter of Oddi in vitro.
We have previously shown that substance P (SP) regulates sphincter of Oddi (SO) motility in vivo. However, its mechanism of action remains unclear. Our aim was to develop an in vitro model to measure spikeburst (SB) an contractile frequency (CMC) of the SO and to characterize further SP effects. In 16 opossums, SO rings were excised, mounted within a Kreb's tissue bath with bipolar electrodes and force transducers, allowed to equilibrate, and exposed to increasing SP concentrations with washout between each test solution. Spikeburst and CMC frequencies were recorded on a polygraph, quantitated, expressed as differences before and during SP, and statistically analyzed with Student's test. Although SP induced a significant concentration-dependent increase in phasic SB frequency and CMC, the amplitude of concentrations was not affected by SP. A close correlation was found between basal and SP-stimulated SB and CMC, suggesting myoelectric and mechanical coupling. Previous exposure of SO to SP antagonist [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP significantly decreased the response to SP. Tetrodotoxin (TTX), did not affect the delta CMC response to SP. In conclusion an in vitro preparation was developed to study the effect of SP on the SO. Substance P increased SB and CMC of the SO in a concentration-dependent fashion, thus acting as a stimulatory peptide. Perfusion of SO rings with SP antagonist had no effect on basal CMC but significantly inhibited the action of SP in a competitive manner. The effect of SP was not altered by TTX. These data suggest that the action of SP on the SO is primarily myogenic.
Department of Surgery, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts 02115.
J E
JE
Parodi
N
N
Cho
M E
ME
Zenilman
J A
JA
Barteau
N J
NJ
Soper
J M
JM
Becker
D000200:Action Potentials / Q000187:drug effects; D014670:Ampulla of Vater / Q000502:physiology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D009119:Muscle Contraction / Q000187:drug effects; D009893:Opossums / Q000502:physiology*; D011994:Recombinant Proteins; D009803:Sphincter of Oddi / Q000187:drug effects / Q000502:physiology*; D013373:Substance P / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D013779:Tetrodotoxin / Q000494:pharmacology
D011994:Recombinant Proteins; D013373:Substance P; D013779:Tetrodotoxin; C050702:substance P, Arg(1)-Pro(2)-Trp(7,9)-Leu(11)-